OpenAlex
PricingAboutJobs
Log inGet started
Work

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

HTML

Year: 2009
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2009-02-202598
Authors: Ulrich Keilholz, Anne Letsch, Antonia Busse, Anne Marie Asemissen, Sandra Bauer, Igor Wolfgang Blau, Wolf-Karsten Hofmann, Lutz Uharek, Eckhard Thiel, Carmen Scheibenbogen
Institution: Charité – Universitätsmedizin Berlin
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: acute myeloid leukemia, myelodysplastic syndrome, refractory anemia with excess blasts, immunogenicity, WT1 mRNA expression, keyhole limpet hemocyanin, GM-CSF, cancer immunotherapy, complete remission
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1992343552
FWCI: 22.24
Cites: 37
Cited by: 325
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms